E
Novavax, Inc. NVAX
$8.88 $4.4198.66%
Recommendation
Sell
Prev Close
$4.47
Volume
733,547
Avg Vol (90D)
7,091,016
Market Cap
$623.13M
Dividend & Yield
--
52-Week Range
$3.53 - $10.30
P/E (TTM)
--
EPS (TTM)
-$5.54
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
5/13/2024 - GuruFocus
Q1 2024 Novavax Inc Earnings Call Transcript
5/13/2024 - GuruFocus
Novavax: Sanofi Partnership Revitalizes My Magnum Opus
5/12/2024 - SeekingAlpha
Novavax: Sanofi Partnership Revitalizes My Magnum Opus
5/12/2024 - Seeking Alpha - Long Ideas
Novavax (NASDAQ:NVAX) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS
5/12/2024 - Ticker Report
Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript
5/12/2024 - SeekingAlpha
Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript
5/12/2024 - Seeking Alpha: Transcripts
Novavax (NVAX, $8.88) RSI Indicator left the overbought zone on May 10, 2024
5/11/2024 - Tickeron - Stocks
Novavax (NVAX, $8.88) price moved above its 50-day Moving Average on May 10, 2024
5/11/2024 - Tickeron - Stocks
Novavax (NVAX, $8.88) price may drop as it broke higher Bollinger Band on May 10, 2024
5/11/2024 - Tickeron - Stocks
Novavax's sudden rise burns short sellers: report
5/11/2024 - SeekingAlpha.com: All News
Novavax's sudden rise burns short sellers: report
5/11/2024 - Seeking Alpha - Healthcare
BP, Disney, Novavax, SharkNinja, ITV, Hipgnosis, Robinhood, Peloton Markets Defused
5/11/2024 - Proactive Investors - UK
Wall Street closes up, another weekly gain ahead of inflation data
5/11/2024 - The Malay Mail Money
Novavax (NASDAQ:NVAX) Hits New 1-Year High at $11.00
5/10/2024 - Ticker Report
Novavax's 99% Surge Gives 'Rib-Crunching' Squeeze to Shorts
5/10/2024 - Yahoo! Finance: News
Noteworthy Friday Option Activity: NVAX, AVGO, INSM
5/10/2024 - Stock Options Channel
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal
5/10/2024 - Bloomberg Markets and Finance-YouTube
Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade)
5/10/2024 - SeekingAlpha
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
5/10/2024 - GuruFocus
Planet Fitness Price Increase: Goodbye $10 Membership Plans
5/10/2024 - InvestorPlace
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
5/10/2024 - Yahoo! Finance: News
Why Novavax Stock More Than Doubled Today
5/10/2024 - Fool.com Headlines
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
5/10/2024 - InvestorPlace
Novavax stock soars on $1.2 billion Sanofi vaccine deal
5/10/2024 - Yahoo! Finance-YouTube
Income Statement
Total Revenue (TTM)
$983.71M
EBITDA (TTM)
-$510.59M
EBIT (TTM)
-$551.81M
Net Income (TTM)
-$545.06M
Balance Sheet
Total Assets (Q)
$1.80B
Total Debt (Q)
$280.64M
Total Liabilities (Q)
$2.51B
Book Value Per Share (Q)
-$5.14
Cash Flow
Cash from Operations (TTM)
-$713.97M
Cash from Investing (TTM)
-$58.81M
Cash from Financing (TTM)
$4.47M
Net Change in Cash (TTM)
-$765.04M
Filings
Filing Date
Wednesday, February 28, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of May 6 and 10 (est)
Price History
Loading...
Beta
1.56
7-Day Total Return
-5.10%
30-Day Total Return
-3.87%
60-Day Total Return
3.95%
90-Day Total Return
-8.59%
Year to Date Total Return
-11.13%
1-Year Total Return
-49.72%
2-Year Total Return
-89.59%
3-Year Total Return
-96.77%
5-Year Total Return
-22.40%
52-week Low
Feb 05, 2024 - $3.53
52-week High
Sep 06, 2023 - $10.30
Valuation
Market Cap
$623.13M - Small Cap
Enterprise Value
$335.26M
Price/Sales (TTM)
0.56
Price/Book (Q)
-0.87
Dividends and Shares
Shares Outstanding
123.68M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.novavax.com
Phone Number
240 268 2000
Address
700 Quince Orchard Road
Gaithersburg, MD 20878
Country
United States
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine... more
NASDAQ 05/10/2024 4:00PM Eastern Quotes delayed
Weiss Ratings